Blueprint Medicines (BPMC) News Today → Urgent Nvidia Warning (From Altimetry) (Ad) Free BPMC Stock Alerts $107.00 +12.14 (+12.80%) (As of 05/2/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineQ1 2024 Blueprint Medicines Corp Earnings Callfinance.yahoo.com - May 3 at 12:55 AMBlueprint Medicines Shares Hit 52-Week on Strong Ayvakit Salesmarketwatch.com - May 2 at 12:54 PMBPMC Stock Earnings: Blueprint Medicines Beats EPS, Beats Revenue for Q1 2024msn.com - May 2 at 12:54 PMBlueprint Medicines Corp Reports Q1 2024 Earnings, Surpasses Revenue Estimates and Raises ...finance.yahoo.com - May 2 at 12:54 PMBlueprint Medicines (NASDAQ:BPMC) Hits New 52-Week High at $107.56marketbeat.com - May 2 at 12:08 PMBlueprint Medicines Corporation 2024 Q1 - Results - Earnings Call Presentationseekingalpha.com - May 2 at 11:29 AMBlueprint Medicines (NASDAQ:BPMC) Stock Rating Reaffirmed by Needham & Company LLCmarketbeat.com - May 2 at 8:23 AMBlueprint Medicines Reports Strong First Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidanceprnewswire.com - May 2 at 7:00 AMJackson Creek Investment Advisors LLC Purchases New Stake in Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - April 30 at 5:34 PMBlueprint Medicines Co. (NASDAQ:BPMC) Given Average Rating of "Moderate Buy" by Brokeragesamericanbankingnews.com - April 30 at 3:12 AMBlueprint Medicines Co. (NASDAQ:BPMC) Receives Average Recommendation of "Moderate Buy" from Analystsmarketbeat.com - April 30 at 2:33 AMRigel Pharmaceuticals: No Respect With Little Justification, Worth Considering A Buyseekingalpha.com - April 29 at 8:38 AMFederated Hermes Inc. Buys Shares of 24,043 Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - April 29 at 5:01 AMBlueprint Medicines (NASDAQ:BPMC) PT Raised to $130.00americanbankingnews.com - April 28 at 2:46 AMBlueprint Medicines (NASDAQ:BPMC) Stock Rating Reaffirmed by HC Wainwrightamericanbankingnews.com - April 28 at 2:46 AMNeedham & Company LLC Reiterates "Buy" Rating for Blueprint Medicines (NASDAQ:BPMC)americanbankingnews.com - April 28 at 2:46 AMWedbush Reiterates "Outperform" Rating for Blueprint Medicines (NASDAQ:BPMC)americanbankingnews.com - April 28 at 2:46 AMState of New Jersey Common Pension Fund D Sells 13,058 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - April 27 at 8:22 AMRubrik to debut on NYSE, IPO priced at $32 per sharefinance.yahoo.com - April 26 at 3:00 PMStifel Nicolaus Increases Blueprint Medicines (NASDAQ:BPMC) Price Target to $130.00marketbeat.com - April 26 at 12:40 PMBlueprint Medicines' (BPMC) "Outperform" Rating Reiterated at Wedbushmarketbeat.com - April 26 at 11:16 AMBlueprint Medicines Corporation: A Strong Buy on Robust Pipeline and Market Potential for Mast Cell Disease Treatmentsmarkets.businessinsider.com - April 26 at 9:59 AMThe Analyst Verdict: Blueprint Medicines In The Eyes Of 7 Expertsmarkets.businessinsider.com - April 26 at 9:59 AMSemanteon Capital Management LP Makes New $1.18 Million Investment in Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - April 25 at 10:36 PMBlueprint Medicines (BPMC) to Release Quarterly Earnings on Thursdaymarketbeat.com - April 24 at 6:28 AMPiper Sandler Keeps Their Hold Rating on Blueprint Medicines (BPMC)markets.businessinsider.com - April 22 at 10:20 PMBlueprint Medicines Co. (NASDAQ:BPMC) Stock Position Trimmed by Raymond James & Associatesmarketbeat.com - April 22 at 4:09 AMBlueprint Medicines to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024prnewswire.com - April 18 at 8:00 AMReadystate Asset Management LP Takes $3.69 Million Position in Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - April 17 at 10:38 PMBlueprint Medicines Co. (NASDAQ:BPMC) Sees Large Drop in Short Interestmarketbeat.com - April 14 at 5:32 PMBlueprint Medicines to Host Webcast and Conference Call Highlighting Emerging Opportunities for Mast Cell-Targeted Therapeuticsprnewswire.com - April 11 at 8:00 AMDecoding 6 Analyst Evaluations For Blueprint Medicinesmarkets.businessinsider.com - April 10 at 5:55 PMBlueprint Medicines Buy Rating: Promising BLU-222 Efficacy and Strong Financial Outlookmarkets.businessinsider.com - April 10 at 12:55 PMJMP Securities Reiterates "Market Outperform" Rating for Blueprint Medicines (NASDAQ:BPMC)marketbeat.com - April 10 at 11:26 AMPeregrine Capital Management LLC Sells 54,890 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - April 10 at 9:49 AMSG Americas Securities LLC Sells 28,025 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - April 6 at 4:15 AMBlueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)prnewswire.com - April 4 at 4:01 PMBlueprint Medicines Co. (NASDAQ:BPMC) CFO Michael Landsittel Sells 5,000 Sharesinsidertrades.com - April 2 at 4:14 AMBlueprint Medicines Corporation (NASDAQ:BPMC): When Will It Breakeven?finance.yahoo.com - March 29 at 8:08 AMVanguard Group Inc. Acquires 37,716 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - March 28 at 4:23 AMAssenagon Asset Management S.A. Acquires 260,321 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)marketbeat.com - March 27 at 6:49 AMJeffrey W. Albers Sells 11,033 Shares of Blueprint Medicines Co. (NASDAQ:BPMC) Stockinsidertrades.com - March 27 at 5:09 AMBlueprint Medicines Co. (NASDAQ:BPMC) Director Jeffrey W. Albers Sells 11,033 Sharesmarketbeat.com - March 27 at 12:15 AMBlueprint Medicines Co. (NASDAQ:BPMC) Director Sells $2,188,371.44 in Stockinsidertrades.com - March 23 at 8:44 AMBlueprint Medicines Co. (NASDAQ:BPMC) Director Jeffrey W. Albers Sells 25,073 Sharesmarketbeat.com - March 22 at 8:09 PMBlueprint Medicines executive sells stock worth over $399kinvesting.com - March 21 at 11:38 PMFirst Week of May 17th Options Trading For Blueprint Medicines (BPMC)nasdaq.com - March 21 at 11:38 PMBlueprint Medicines (NASDAQ:BPMC) Stock Price Down 3% Following Insider Sellingmarketbeat.com - March 20 at 10:35 AMBlueprint Medicines Co. (NASDAQ:BPMC) CFO Michael Landsittel Sells 13,734 Sharesinsidertrades.com - March 20 at 6:34 AMInsider Selling: Blueprint Medicines Co. (NASDAQ:BPMC) CFO Sells 13,734 Shares of Stockmarketbeat.com - March 19 at 7:31 PM Get Blueprint Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for BPMC and its competitors with MarketBeat's FREE daily newsletter. Email Address Urgent dollar warning (Ad)Your 2024 Election Money Blueprint Voters are angrier than ever, and it's likely to keep getting worse. The media and Wall Street keep declaring how great the economy supposedly is... but no one – besides the ultra-rich – seems to feel that way. Protect yourself with this one simple move today. Find out for free here. BPMC Media Mentions By Week BPMC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BPMC News Sentiment▼0.380.33▲Average Medical News Sentiment BPMC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BPMC Articles This Week▼285▲BPMC Articles Average Week Get Blueprint Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for BPMC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: APLS News Today IONS News Today BBIO News Today OGN News Today CYTK News Today ELAN News Today PRGO News Today NUVL News Today ALPN News Today ITCI News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BPMC) was last updated on 5/3/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldThe AI stock to buy right nowStockEarningsCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetry$5,000 Gold?Stansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithYour bank is lying to you.MyBankTracker Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Blueprint Medicines Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
